Jubilant Life Sciences gets USFDA nod for Indomethacin capsules
NEW DELHI: Drug firm Jubilant Life Sciences has received approval from the US health regulator to market Indomethacin capsule used for treating pains.In a BSE filing, Jubilant Life Sciences said it "received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Indomethacin ER Capsule 75mg, which is a non-steriodal anti-inflammatory drug...
Login or Register to read the full article
NEW DELHI: Drug firm Jubilant Life Sciences has received approval from the US health regulator to market Indomethacin capsule used for treating pains.
In a BSE filing, Jubilant Life Sciences said it "received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Indomethacin ER Capsule 75mg, which is a non-steriodal anti-inflammatory drug used for treatment of pain
Jubilant Life Sciences said as on June 30, 2015, it had a total of 815 filings for formulations of which 389 have been approved in various regions globally.
"This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe," it added.
Jubilant Life Sciences Limited is a Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery Solutions. The Company provides offerings of Pharmaceutical and Life Sciences products and services across the value chain. It has 10 manufacturing facilities in India, US and Canada and a team of about 6,000 multicultural people across the globe.
In a BSE filing, Jubilant Life Sciences said it "received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Indomethacin ER Capsule 75mg, which is a non-steriodal anti-inflammatory drug used for treatment of pain
Jubilant Life Sciences said as on June 30, 2015, it had a total of 815 filings for formulations of which 389 have been approved in various regions globally.
"This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe," it added.
Jubilant Life Sciences Limited is a Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery Solutions. The Company provides offerings of Pharmaceutical and Life Sciences products and services across the value chain. It has 10 manufacturing facilities in India, US and Canada and a team of about 6,000 multicultural people across the globe.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd